论文部分内容阅读
目的:评价口服普萘洛尔治疗婴儿血管瘤的疗效及不良反应。方法:对120例普萘洛尔治疗至少6个月以上的婴儿血管瘤患者的临床疗效和不良反应进行评价。结果:120例患儿服药3个月有效率为59.2%,6个月有效率为96.46%,82例停药时有效率为98.78%。不良反应的发生率为21.67%。结论:口服普萘洛尔治疗婴儿血管瘤疗效好、不良反应少且轻。
Objective: To evaluate the efficacy and adverse reactions of oral propranolol in the treatment of infantile hemangiomas. Methods: 120 patients with propranolol treatment of at least 6 months or more in patients with hemangiomas clinical efficacy and adverse reactions were evaluated. Results: The effective rate of three cases in 120 children was 59.2% at 3 months, 96.46% at 6 months, and 98.78% at 82 cases. The incidence of adverse reactions was 21.67%. Conclusion: Propranolol is effective in treating infantile hemangiomas with less adverse reactions and less adverse effects.